Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The co… Read more
Market Cap & Net Worth: Voyageur Pharmaceuticals Ltd (VYYRF)
Voyageur Pharmaceuticals Ltd (PINK:VYYRF) has a market capitalization of $14.28 Million ($14.28 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #27384 globally and #9176 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Voyageur Pharmaceuticals Ltd's stock price $0.08 by its total outstanding shares 178438125 (178.44 Million).
Voyageur Pharmaceuticals Ltd Market Cap History: 2017 to 2025
Voyageur Pharmaceuticals Ltd's market capitalization history from 2017 to 2025. Data shows growth from $14.54 Million to $14.28 Million (4.26% CAGR).
Voyageur Pharmaceuticals Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Voyageur Pharmaceuticals Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VYYRF by Market Capitalization
Companies near Voyageur Pharmaceuticals Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Voyageur Pharmaceuticals Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Voyageur Pharmaceuticals Ltd Historical Marketcap From 2017 to 2025
Between 2017 and today, Voyageur Pharmaceuticals Ltd's market cap moved from $14.54 Million to $ 14.28 Million, with a yearly change of 4.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $14.28 Million | +3900.00% |
| 2024 | $356.88K | -95.00% |
| 2023 | $7.14 Million | -39.67% |
| 2022 | $11.83 Million | +14.11% |
| 2021 | $10.37 Million | +21.04% |
| 2020 | $8.57 Million | +15.38% |
| 2019 | $7.42 Million | -26.11% |
| 2018 | $10.05 Million | -30.92% |
| 2017 | $14.54 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Voyageur Pharmaceuticals Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.28 Million USD |
| MoneyControl | $14.28 Million USD |
| MarketWatch | $14.28 Million USD |
| marketcap.company | $14.28 Million USD |
| Reuters | $14.28 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.